Vaccine maker Bharat Biotech plans to conduct Phase III clinical trial for COVID-19 vaccine candidate Covaxin from November.The company, which is developing the vaccine in collaboration with the Indian Council of Medical Research (ICMR), intends to conduct the trial on 26,000 volunteers across 25 cities in the country, sources said.This move follows the company getting Drugs Controller General of India (DCGI) approval to conduct the Phase III clinical trial for Covaxin.

Vaccine maker Bharat Biotech plans to conduct Phase III clinical trial for COVID-19 vaccine candidate Covaxin from November.The company, which is developing the vaccine in collaboration with the Indian Council of Medical Research (ICMR), intends to conduct the trial on 26,000 volunteers across 25 cities in the country, sources said.This move follows the company getting Drugs Controller General of India (DCGI) approval to conduct the Phase III clinical trial for Covaxin.